Why insider trading matters?
When insiders buy shares on the open market, this can thus be regarded as a strong endorsement by those that know the company the best -- they are literally betting their own money on the company's future. Insider selling, however, is not necessarily meaningful in any way, as there is a range of reasons for insiders to liquidate (some) of the shares they own.
Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies. Its lead product candidate is CPI-444, an oral, small molecule antagonist of the A2A receptor that is in Phase I/Ib clinical trial for adenosine, an immune checkpoint.
| Trade Date | Insider | Title | Buy/Sell | #Shares | Price | Value | Option |
|---|---|---|---|---|---|---|---|
| 2021-05-04 | MILLER RICHARD A MD | President and CEO | Buy | 35,714 | $2.80 | $99,999 | No |
| 2021-02-17 | ORBIMED ADVISORS LLC | 10%-Owner, Director | Buy | 1,285,714 | $3.50 | $4,499,999 | No |
| 2021-02-17 | Thompson Peter A. | 10%-Owner, Director | Buy | 1,285,714 | $3.50 | $4,499,999 | No |
| 2021-02-17 | MILLER RICHARD A MD | President and CEO | Buy | 100,000 | $3.50 | $350,000 | No |
| 2020-07-08 | Novo Holdings A/S | 10%-Owner | Sell | 1,538,062 | $5.31 | $8,168,547 | No |
| 2019-11-13 | MILLER RICHARD A MD | President and CEO | Buy | 15,008 | $3.00 | $45,029 | No |
| 2019-08-06 | Thompson Peter A. | 10%-Owner, Director | Buy | 142,656 | $3.51 | $500,723 | No |
| 2019-08-06 | ORBIMED ADVISORS LLC | 10%-Owner, Director | Buy | 142,656 | $3.51 | $500,723 | No |
| 2019-08-07 | MILLER RICHARD A MD | President and CEO | Buy | 7,500 | $3.56 | $26,725 | No |
| 2019-07-25 | Novo Holdings A/S | 10%-Owner | Sell | 1,492,956 | $4.07 | $6,077,845 | No |
| 2019-07-01 | Thompson Peter A. | 10%-Owner, Director | Buy | 657,344 | $3.72 | $2,444,065 | No |
| 2019-07-01 | ORBIMED ADVISORS LLC | 10%-Owner, Director | Buy | 657,344 | $3.72 | $2,444,065 | No |
| 2019-06-14 | MILLER RICHARD A MD | President and CEO | Buy | 12,000 | $3.41 | $40,874 | No |
| 2019-06-11 | MILLER RICHARD A MD | President and CEO | Buy | 15,212 | $3.49 | $53,039 | No |
| 2019-06-07 | LEA LEIV | Chief Financial Officer | Buy | 25,500 | $3.49 | $88,980 | No |
| 2018-12-27 | MILLER RICHARD A MD | President and CEO | Buy | 20,000 | $3.29 | $65,884 | No |
| 2018-12-21 | LEA LEIV | Chief Financial Officer | Buy | 24,700 | $4.15 | $102,409 | No |
| 2018-12-20 | MILLER RICHARD A MD | President and CEO | Buy | 10,000 | $4.39 | $43,950 | No |
| 2018-12-06 | MILLER RICHARD A MD | President and CEO | Buy | 5,000 | $5.99 | $29,934 | No |
| 2018-12-04 | MILLER RICHARD A MD | President and CEO | Buy | 1,502 | $5.95 | $8,937 | No |
| 2018-03-12 | Thompson Peter A. | 10%-Owner, Director | Buy | 588,235 | $8.50 | $4,999,998 | No |
| 2018-03-12 | ORBIMED ADVISORS LLC | 10%-Owner, Director | Buy | 588,235 | $8.50 | $4,999,998 | No |
| 2018-03-12 | Novo Holdings A/S | 10%-Owner | Buy | 1,176,470 | $8.50 | $9,999,995 | No |
| 2018-03-12 | Gould Terry P | 10%-Owner, Director | Buy | 588,235 | $8.50 | $4,999,998 | No |
| 2018-03-12 | ADAMS STREET PARTNERS LLC | 10%-Owner | Buy | 588,235 | $8.50 | $4,999,998 | No |
| 2018-03-12 | MILLER RICHARD A MD | President and CEO | Buy | 100,000 | $8.50 | $850,000 | No |
| 2017-11-20 | MILLER RICHARD A MD | President and CEO | Buy | 10,000 | $10.79 | $107,850 | No |
| 2017-06-23 | Novo Holdings A/S | 10%-Owner | Buy | 20,000 | $10.95 | $219,000 | No |
| 2017-06-13 | MILLER RICHARD A MD | President and CEO | Buy | 25,000 | $9.88 | $247,084 | No |
| 2016-06-24 | Thompson Peter A. | 10%-Owner, Director | Buy | 1,000 | $12.98 | $12,983 | No |
Insider Smart
Insider Smart